LB Pharmaceuticals Inc Common Stock (LBRX)
Healthcare
Biotechnology
42.80 $
+6.9%
vs. previous close
Closing price · As of: 3. Aug 2026
LB Pharmaceuticals Inc Common Stock (LBRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -35 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -2.7 | -12 | -53 | -35 | |
| 0.0 | 0.0 | 0.1 | 0.3 | |
| 0.4 | 0.3 | 3.2 | 4.2 | |
| 0.1 | -1.3 | 3.3 | -14 | |
| 0.0 | 0.0 | 0.8 | 0.1 | |
| 0.1 | -28 | 23 | -40 | |
| 25 | 0.7 | 0.0 | – | |
| 23 | 34 | 38 | 303 | |
| 20 | -6.4 | 8.5 | 227 | |
| -2.7 | -12 | -54 | -35 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.